Monitoring Monoclonal Antibody Delivery in Oncology: The Example of Bevacizumab
Posted on 2013-08-12 - 01:43
Fluorescence intensity was measured on 15 independent assays over a large bevacizumab range (0–6 mg/mL).
CITE THIS COLLECTION
DataCiteDataCite
3 Biotech3 Biotech
3D Printing in Medicine3D Printing in Medicine
3D Research3D Research
3D-Printed Materials and Systems3D-Printed Materials and Systems
4OR4OR
AAPG BulletinAAPG Bulletin
AAPS OpenAAPS Open
AAPS PharmSciTechAAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität HamburgAbhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)ABI Technik (German)
Academic MedicineAcademic Medicine
Academic PediatricsAcademic Pediatrics
Academic PsychiatryAcademic Psychiatry
Academic QuestionsAcademic Questions
Academy of Management DiscoveriesAcademy of Management Discoveries
Academy of Management JournalAcademy of Management Journal
Academy of Management Learning and EducationAcademy of Management Learning and Education
Academy of Management PerspectivesAcademy of Management Perspectives
Academy of Management ProceedingsAcademy of Management Proceedings
Academy of Management ReviewAcademy of Management Review
Nugue, Guillaume; Bidart, Marie; Arlotto, Marie; Mousseau, Mireille; Berger, François; Pelletier, Laurent (2015). Monitoring Monoclonal Antibody Delivery in Oncology: The Example of Bevacizumab. PLOS ONE. Collection. https://doi.org/10.1371/journal.pone.0072021
or cite all items
Select your citation style and then place your mouse over the citation text to select it.
SHARE
Usage metrics
Read the peer-reviewed publication
AUTHORS (6)
GN
Guillaume Nugue
MB
Marie Bidart
MA
Marie Arlotto
MM
Mireille Mousseau
FB
François Berger
LP
Laurent Pelletier
CATEGORIES
need help?Follow this search